Home›Stock Screener›Indegene›P/B Ratio

Indegene P/B Ratio

Current P/B Ratio
3.9
High Valuation
High - Premium to book value, growth expectations or asset-light model

Indegene (INDGN) P/B ratio is 3.9 (High), book value per share ₹653.96 vs Healthcare average P/B of -0.31 — High - Premium to book value, growth expectations or asset-light model. View INDGN 52-week high low for the annual high/low range and current price position.

Current Valuation Metrics

P/B Ratio 3.9
Current Price ₹492.65
Book Value/Share ₹653.96
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹3,139 Cr
Share Capital ₹48 Cr
Reserves & Surplus ₹3,090 Cr
Outstanding Shares 48,000,000
Book Value per Share ₹653.96

Valuation Signal

Signal Overvalued
Historical Avg 1.19
Historical Range 0.75 - 1.86
Percentile 100.0%

Sector Context

Sector Average -0.31
Sector Median 0.57
Sector Rank #11 of 50
Sector Percentile 22.0%

INDGN P/B Ratio — Valuation Insights & Book Value Analysis

Indegene price-to-book ratio interpretation, valuation status and historical context — current P/B 3.9 (High). Review INDGN P/E comparison to evaluate earnings-based valuation against sector peers.

  • Stock appears overvalued with PB of 3.9, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 228.7% above historical average
  • Trading at premium to sector average PB of -0.31

Indegene P/B Ratio Historical Trend

INDGN annual price-to-book ratio — 3 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Indegene screener.

INDGN Historical P/B Ratio — Book Value Per Share & Year-End Price

Indegene annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 0.75 ₹653.96 ₹492.65 ₹3,139 Low
2025 0.95 ₹545.0 ₹520.45 ₹2,616 Low
2024 1.86 ₹324.77 ₹603.70 ₹1,429 Moderate

INDGN vs Healthcare Peers — P/B Ratio Comparison

Indegene P/B 3.9 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.

Sector Average
-0.31
Sector Median
0.57
Lowest P/B
-14.47
Highest P/B
1.1
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -14.47 ₹18 Low
Span Divergent SDL -6.32 ₹19 Low
Parmax Pharma PARMAX -5.61 ₹39 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.22 ₹72 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹115 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.5 ₹44 Low